Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
FDA Category 2 status AOD-9604 was previously nominated for inclusion under FDA's Category 2 list (substances proposed for compounding under research/evaluation)
Published research on PT-141 is indexed on PubMed
9 , CD011612 (2015)
A Lipase Test becomes more meaningful when a patient has compatible symptoms, particularly persistent severe upper-abdominal pain, and the result is interpreted with examination and imaging when necessary
US$ 26.61
US$ 23.42
US$ 24.54
US$ 23.82
US$ 23.63
US$ 26.15
US$ 24.55
